Items where authors include "Glynne-Jones, R"

Article

Henderson, RH, French, D, McFerran, E et al. (10 more authors) (2022) Spend less to achieve more: Economic analysis of intermittent versus continuous cetuximab in KRAS wild-type patients with metastatic colorectal cancer. Journal of Cancer Policy, 33. 100342. ISSN 2213-5383

Osong, B, Masciocchi, C, Damiani, A et al. (18 more authors) (2022) Bayesian network structure for predicting local tumor recurrence in rectal cancer patients treated with neoadjuvant chemoradiation followed by surgery. Physics and Imaging in Radiation Oncology, 22. pp. 1-7. ISSN 2405-6316

Fokas, E, Appelt, A orcid.org/0000-0003-2792-9218, Glynne-Jones, R et al. (27 more authors) (2021) International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancer. Nature Reviews Clinical Oncology, 18. pp. 805-816. ISSN 1759-4774

Glynne-Jones, R, Meadows, HM, Lopes, A et al. (3 more authors) (2020) Reply to the letter to the editor: DPD testing in radical chemoradiation for anal squamous cell carcinoma? by R. Muirhead, H. Jones, D. Gilbert, A. Gilbert & C. Jacobs. Annals of Oncology, 31 (11). pp. 1587-1588. ISSN 0923-7534

Glynne-Jones, R, Meadows, HM, Lopes, A et al. (4 more authors) (2020) Impact of compliance to chemoradiation on long-term outcomes in squamous cell carcinoma of the anus. Results of a post-hoc analysis from the randomized phase III ACT II trial. Annals of Oncology, 31 (10). pp. 1376-1385. ISSN 0923-7534

Rao, S, Sclafani, F, Eng, C et al. (18 more authors) (2020) International Rare Cancers Initiative Multicenter Randomized Phase II Trial of Cisplatin and Fluorouracil Versus Carboplatin and Paclitaxel in Advanced Anal Cancer: InterAAct. Journal of Clinical Oncology, 38 (22). pp. 2510-2518. ISSN 0732-183X

Marijnen, CAM, Peters, FP, Rödel, C et al. (12 more authors) (2020) International expert consensus statement regarding radiotherapy treatment options for rectal cancer during the COVID 19 pandemic. Radiotherapy and Oncology, 148. pp. 213-215. ISSN 0167-8140

Fokas, E, Glynne-Jones, R, Appelt, A orcid.org/0000-0003-2792-9218 et al. (13 more authors) (2020) Outcome measures in multimodal rectal cancer trials. Lancet Oncology, 21 (5). e252-e264. ISSN 1470-2045

Gilbert, A, Drinkwater, K, McParland, L et al. (7 more authors) (2020) UK national cohort of anal cancer treated with intensity-modulated radiotherapy: One-year oncological and patient-reported outcomes. European Journal of Cancer, 128. pp. 7-16. ISSN 0959-8049

Glynne-Jones, R, Hall, MR, Lopes, A et al. (15 more authors) (2018) BACCHUS: A randomised non-comparative phase II study of neoadjuvant chemotherapy (NACT) in patients with locally advanced rectal cancer (LARC). Heliyon, 4 (9). e00804. ISSN 2405-8440

Jones, CM, Adams, R, Downing, A orcid.org/0000-0002-0335-7801 et al. (6 more authors) (2018) Toxicity, Tolerability, and Compliance of Concurrent Capecitabine or 5-Fluorouracil in Radical Management of Anal Cancer With Single-dose Mitomycin-C and Intensity Modulated Radiation Therapy: Evaluation of a National Cohort. International Journal of Radiation Oncology*Biology*Physics, 101 (5). pp. 1202-1211. ISSN 0360-3016

Sodergren, SC, Johnson, CD, Gilbert, A et al. (13 more authors) (2018) Phase I–III development of the EORTC QLQ-ANL27, a health-related quality of life questionnaire for anal cancer. Radiotherapy and Oncology, 126 (2). pp. 222-228. ISSN 0167-8140

Glynne-Jones, R, Sebag-Montefiore, D, Meadows, HM et al. (9 more authors) (2017) Best time to assess complete clinical response after chemoradiotherapy in squamous cell carcinoma of the anus (ACT II): a post-hoc analysis of randomised controlled phase 3 trial. The Lancet Oncology, 18 (3). pp. 347-356. ISSN 1470-2045

Muirhead, R, Drinkwater, K, O'Cathail, SM et al. (6 more authors) (2017) Initial Results from the Royal College of Radiologists' UK National Audit of Anal Cancer Radiotherapy 2015. Clinical Oncology, 29 (3). pp. 188-197. ISSN 0936-6555

Sodergren, SC, Vassiliou, V, Dennis, K et al. (7 more authors) (2015) Systematic Review of the Quality of Life issues associated with Anal Cancer and its treatment with Radiochemotherapy. Supportive Care in Cancer, 23 (12). 3613 - 3623. ISSN 0941-4355

Glynne-Jones, R, Hava, N, Goh, V et al. (18 more authors) (2015) Bevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): a phase II, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patients with high-risk cancer of the rectum. BMC Cancer, 15. 764. ISSN 1471-2407

Glynne-Jones, R, West, NP orcid.org/0000-0002-0346-6709 and Quirke, P orcid.org/0000-0002-3597-5444 (2015) The D Prefix: Toward a Reproducible Validated Alternative End Point in Rectal Cancer. Diseases of the colon and rectum, 58 (6). pp. 613-616. ISSN 0012-3706

Bogaerts, J, Sydes, MR, Keat, N et al. (43 more authors) (2014) Clinical trial designs for rare diseases: studies developed and discussed by the International Rare Cancers Initiative. European journal of cancer. ISSN 0014-2964

Papamichael, D, Audisio, RA, Glimelius, B et al. (14 more authors) (2014) Treatment of colorectal cancer in older patients. International Society of Geriatric Oncology (SIOG) consensus recommendations 2013. Annals of Oncology. ISSN 1569-8041

Proceedings Paper

Sebag-Montefiore, D, Adams, R, Bell, S et al. (17 more authors) (2016) The Development of an Umbrella Trial (PLATO) to Address Radiation Therapy Dose Questions in the Locoregional Management of Squamous Cell Carcinoma of the Anus. In: Proceedings of the American Society for Radiation Oncology. 58th Annual Meeting of the American Society for Radiation Oncology, 25-28 Sep 2016. Elsevier , E164-E165.